Friday, September 26, 2008

Cervical cancer HPV vaccine on the rise


Gainesville, FL
Gardasil is the only cervical cancer vaccine that helps protect against four types of human papilomavirus. The vaccine was introduced two years ago and recommended that all women between the ages of nine and 26 recieve the vaccine. Director of Student Health Care Center at the University of Florida Phillip Barkley has seen the effects at the Student Health Care center since the vaccine was introduced. Though the vaccine is most effective before women are sexually active, it is still recommended that sexually active women receive the vaccine to help prevent against other forms of H-P-V. Doctors recommend that young women between the ages of nine and twenty six receive the vaccine. However, 11 to 12 year old girls are the best candidates for the vaccine. The vaccine is given in a series of three shots throughout a 6 month period. The vaccine has proved to be most effective when all three shots have been given on time. Since introduced two years ago, there have been concerns about the vaccine. The lifetime, cost, and side effects of the vaccine are all concerns that doctors have been trying to resolve. The vaccine is offered for all female students at the Student Health Center. This vaccine is something Dr. Barkley recommends strongly to all women. He believes it has a strong chance of preventing young women from being diagnosed with cervical cancer. Although the vaccine could prevent up to 70 percent of cervical cancer cases, it can't prevent infection with every virus that causes cervical cancer. Routine Pap tests to screen for cervical cancer remain important.

Labels: ,

 Subscribe to Cervical Cancer News Information Links

Bookmark and Share
posted by iLitigate at

0 Comments:

Post a Comment

<< Home